). Therefore, emodepside inhibits both tem of this animal, emodepside (100 nM) stimulates the tonically-active pharynx, and pharyngeal pumping exocytosis and elicits pharyngeal paralysis. The pharstimulated by pharmacological activation of the enteric ynxes of animals with latrophilin (lat-1) gene knockneuronal circuit. The cyclic structure of emodepside preouts are resistant to emodepside, indicating that emosents the possibility that its action may derive from a depside exerts its high-affinity paralytic effect through nonspecific, receptor-independent pore-forming capa-LAT-1. The expression pattern of lat-1 supports the bility. However, PF1022-001, a structural isomer of the hypothesis that emodepside exerts its effect on the lead compound for emodepside that has the same porepharynx primarily via neuronal latrophilin. We build forming capability [11], has no inhibitory action on the on these observations to show that pharynxes from pharynx at concentrations up to 10 M (n ϭ 6; data not animals with either reduction or loss of function mushown). As a caveat to this, it should be noted that the tations in Gq, phospholipaseC-␤, and UNC-13 are pore-forming capability of LTX in biological membranes resistant to emodepside. The latter is a key priming requires tethering of LTX to the membrane by binding molecule essential for synaptic vesicle-mediated reto specific receptors [12] . Therefore, we cannot discount lease of neurotransmitter [4, 5] . We conclude that the the possibility that the lack of effect of PF1022-001 may small molecule ligand emodepside triggers latrophilinreflect an inability of the isomer to bind to a membrane mediated exocytosis via a pathway that engages UNCreceptor prior to pore formation. 
depolarization (5.8 Ϯ 2.6 mV; n ϭ 4) and inhibited potent effect of emodepside on C. elegans pharynx involves latrophilin. To achieve this, we tested the effect pharyngeal action potential generation ( Figure 2C ). Glutamate depolarizes the pharynx [13] ; however, a putative of emodepside on a putative null gene deletion mutant, lat-1(ok379), and on animals treated with doublenull allele for the glutamate receptor, avr-15(ad1051) [14] , was not resistant to emodepside (n ϭ 10; data stranded RNA (dsRNA) for lat-1 to induce RNA interference (RNAi). Interestingly, both the lat-1 knockout and not shown). Therefore, it is unlikely that the action of emodepside requires glutamate release alone. Perhaps lat-1 RNAi animals had a prolonged pharyngeal pump duration compared to wild-type. For lat-1(ok379), this this is not surprising, because the pharyngeal nervous system expresses a wide range of neurotransmitters was 220 Ϯ 19 ms (n ϭ 11), and for lat-1 RNAi, this was 225 Ϯ 23 ms (n ϭ 21) compared with a wild-type durathat have effects on the pharyngeal muscle [10], any or all of which could be released by an LTX-like action of tion of 162 Ϯ 16 ms [n ϭ 22; p Ͻ 0.05 with respect to lat-1(ok379); Figure 3A ] and a duration of 180 Ϯ 13 ms emodepside. We conclude that the effect of emodepside on pharyngeal membrane potential is likely to be (n ϭ 17) in the RNAi control (zero IPTG control; p Ͻ 0.05 with respect to lat-1 RNAi). Extended pharyngeal pump the net result of release of multiple neurotransmitters.
Previous studies have shown that emodepside interduration is also observed in C. elegans mutants with defective neurotransmission [16] , although the effect acts with nematode latrophilin [3] . There are two candidate latrophilins in C. elegans through which emodepobserved in the lat-1 knockouts was not as marked. These observations are consistent with the idea that side may exert its effect, lat-1 (B0457.1) and lat-2 (B0286.2). Both lat-1 and lat-2 encode seven transmemlatrophilin has a physiological role in facilitating neurotransmitter release. Support for this also comes from a brane domain, Family 2, G protein-coupled receptors with characteristics of latrophilins, including large exstudy in Drosophila showing that mutations in the G protein-coupled receptor Methuselah (Mth), related to tracellular and intracellular domains, a lectin-like sequence, a G protein proteolysis site domain (GPS), and latrophilin, results in a 50% decrease in evoked transmitter release [17] . We also observed that lat-1(ok379) were a short cysteine-rich sequence [15] (Figure S2 ). LAT-1 has 22, 23, and 21% amino acid identities to rat, bovine, constipated, similar to an earlier report that RNAi for lat-1 has this effect [18] . Importantly, these observations and human latrophilin, respectively. LAT-1 and LAT-2 have 21% amino acid identity with each other.
are indicative of physiological regulation of latrophilin by an endogenous ligand. We performed experiments to determine whether the The pharynxes of lat-1(ok379) animals were resistant to emodepside and continued to pump at concentrations up to 100 nM emodepside (Table 1; Figure 3B ). This is corroborated by a similar observation for lat-1 RNAi (Table 1; Figure 3B ). In contrast, emodepside was still effective at inhibiting locomotion in the lat-1 knockout, with a potency indistinguishable from wild-type (data not shown). This suggests that some other receptor, perhaps lat-2, may be involved in mediating the inhibitory action of emodepside on locomotion. In support of this, dsRNA targeted at lat-2 and a lat-2 gene deletion mutant were both resistant to the effects of emodepside on locomotion (data not shown).
Overall, the data support the conclusion that in C. elegans pharynx, LAT-1 plays a pivotal role in the highaffinity effect of emodepside. We found support for this when examining the expression pattern of lat-1, by using a lat-1::DsRed2 reporter construct. In larval stages, expression was most evident in the pharyngeal muscle, consistent with earlier reports that used immunostaining [6] (Figures 3C and 3D ). There may also have been neuronal expression in the larva, but this was hard to discern in the pharynx region. However, in adults, lat-1 expression appeared to be lost from the muscle but was expressed in anterior neurons, both extra-pharyngeal and pharyngeal, including one neuron in the terminal bulb and neurons of the corpus, with projections into the isthmus (Figures 3E and 3F) . Notably, in the pharynx of adult animals, which are most susceptible to emodepside, lat-1 is expressed in neurons rather than muscle.
These observations, derived from using pharyngeal activity in C. elegans to determine the effect of emodepside, are consistent with the idea that it acts via a neuronal latrophilin-signaling pathway. We gained further insight into this pathway by screening for emodepside resistance in several strains with mutations in genes encoding candidate effector molecules. As latrophilin copurifies with Gq␣ and Go␣ in mammalian cells [19] , 
